- Home
- PBYI vs SSP Comparison
PBYI vs SSP Comparison
Compare PBYI & SSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- SSP
- Stock Information
- Founded
- PBYI 2010
- SSP 1878
- Country
- PBYI United States
- SSP United States
- Employees
- PBYI N/A
- SSP N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- SSP Broadcasting
- Sector
- PBYI Health Care
- SSP Industrials
- Exchange
- PBYI Nasdaq
- SSP Nasdaq
- Market Cap
- PBYI 164.3M
- SSP 252.6M
- IPO Year
- PBYI N/A
- SSP 1988
- Fundamental
- Price
- PBYI $3.54
- SSP $3.17
- Analyst Decision
- PBYI Strong Buy
- SSP Strong Buy
- Analyst Count
- PBYI 1
- SSP 1
- Target Price
- PBYI $7.00
- SSP $8.00
- AVG Volume (30 Days)
- PBYI 306.9K
- SSP 906.8K
- Earning Date
- PBYI 07-31-2025
- SSP 08-07-2025
- Dividend Yield
- PBYI N/A
- SSP N/A
- EPS Growth
- PBYI 143.51
- SSP N/A
- EPS
- PBYI 0.77
- SSP 0.93
- Revenue
- PBYI $232,709,000.00
- SSP $2,472,701,000.00
- Revenue This Year
- PBYI N/A
- SSP N/A
- Revenue Next Year
- PBYI N/A
- SSP $9.51
- P/E Ratio
- PBYI $4.64
- SSP $3.57
- Revenue Growth
- PBYI 2.68
- SSP 6.28
- 52 Week Low
- PBYI $2.23
- SSP $1.36
- 52 Week High
- PBYI $4.13
- SSP $4.06
- Technical
- Relative Strength Index (RSI)
- PBYI 58.61
- SSP 67.71
- Support Level
- PBYI $3.26
- SSP $2.70
- Resistance Level
- PBYI $3.65
- SSP $3.17
- Average True Range (ATR)
- PBYI 0.14
- SSP 0.22
- MACD
- PBYI 0.01
- SSP 0.03
- Stochastic Oscillator
- PBYI 84.78
- SSP 94.74
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About SSP E.W. Scripps Company (The)
The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.